An antiserum to idazoxan recognizes an immunoreactive substance in human serum and cerebral spinal fluid which is not agmatine
Open Access
- 31 January 1997
- journal article
- Published by Elsevier in Neurochemistry International
- Vol. 30 (1) , 85-94
- https://doi.org/10.1016/s0197-0186(96)00041-1
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Agmatine, the bacterial amine, is widely distributed in mammalian tissuesLife Sciences, 1995
- Identifying Clonidine-Displacing SubstanceScience, 1994
- A circulating substance cross-reacting with antiimidazoline antibodies. Detection in serum in relation to essential hypertension.Journal of Clinical Investigation, 1993
- Polyclonal anti-idazoxan antibodies: characterization and purificationEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Production and characterization of an iminoimidazolidine specific monoclonal antibody using para-aminoclonidine as antigenLife Sciences, 1992
- Human plasma‐derived material with clonidine displacing substance (CDS)‐like properties contracts the isolated rat aortaJournal of Autonomic Pharmacology, 1991
- Clonidine-specific antisera recognize an endogenous clonidine-displacing substance in brain.Hypertension, 1989
- A specific antiserum recognizes clonidine-displacing substance: Implications for the structure of the brain's own clonidineNeuroscience Letters, 1988
- An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medullaLife Sciences, 1986
- An endogenous brain substance, CDS (clonidine-displacing-substance), inhibits the twitch response of rat vas deferensBiochemical and Biophysical Research Communications, 1986